Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 31 min ago
Peer-reviewedLicence not statedNew England Journal of Medicine

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Related

  1. Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia: a multicenter real-world evaluation using the international TriNetX database
    Natesan Ramsamy, Maïa Simon, Isabelle Adam +6
    Antimicrobial Agents and ChemotherapyPeer-reviewedCC BY-NC-SA 4.0Full textGeneral biologyInfectious diseaseHAL
  2. Cefazolin versus Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    F. Pozzebon, G. Pacheco, G. Cabral +3
    medRxivPreprintCC BY-NC-NDFull textInfectious diseasemedRxiv
  3. Routine Serial Follow-up Blood Cultures After a Negative Result Within 48 Hours of Methicillin-susceptible Staphylococcus aureus Bacteremia: Low Yield, High Cost
    Marianne M C Hendriks, Eline H H M Kamps, Cairo Norberhuis +6
    Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of AmericaPeer-reviewedCC BY 4.0Full text1 citedInfectious diseasePMC
  4. Chlorhexidine MIC distribution, efflux pump gene profiles, and genotypic characteristics among clinical methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates
    Mina Golban, Javad Charostad, Hossein Kazemian +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseCrossref
  5. From Heart Murmur to Bone Involvement: Tricuspid Valve Endocarditis With First-Rib Osteomyelitis in a Patient With Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
    Tanner Besse, Rodolfo Loureiro, Nicholena Richardson +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{group2026cefazolin,
  title = {{Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia}},
  author = {The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group},
  journal = {New England Journal of Medicine},
  year = {2026},
  month = jun,
  doi = {10.1056/nejmoa2506905},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7619232/},
}
RIS
TY  - JOUR
TI  - Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
AU  - The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
PY  - 2026
DA  - 2026/06/17
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa2506905
UR  - https://pmc.ncbi.nlm.nih.gov/articles/PMC7619232/
SN  - 0028-4793
SN  - 0096-6762
SN  - 1533-4406
SN  - 2331-4710
ER  -